Strata Critical Medical, Inc. SRTA
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -113.26% | -180.95% | 161.67% | 9.80% | 3,038.38% |
| Total Depreciation and Amortization | 406.02% | 187.41% | 150.00% | 180.34% | 12.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 109.07% | 166.66% | -88.46% | 39.17% | -2,318.68% |
| Change in Net Operating Assets | -96.07% | 71.36% | -301.91% | -5,256.09% | 241.91% |
| Cash from Operations | 125.36% | 285.61% | 1,679.27% | -374.14% | -686.89% |
| Capital Expenditure | 86.20% | -11.41% | -98.13% | 59.62% | 68.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 98.47% | -- | -- | -- | -2,822.60% |
| Divestitures | 100.00% | -- | -- | -- | -- |
| Other Investing Activities | -79.28% | -121.25% | 31.18% | 169.45% | 6,566.28% |
| Cash from Investing | 461.34% | -253.00% | 21.18% | 359.38% | 118.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -93.85% | -78.57% | -13.33% | 22.73% | 490.91% |
| Repurchase of Common Stock | -120.63% | -265.42% | 86.48% | 54.16% | -149.60% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -129.38% | -270.45% | 79.77% | 55.03% | -144.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 100.00% | -1,093.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 150.45% | -272.17% | 73.03% | 567.08% | -435.95% |